Dendreon continues to bulk up as it anticipates FDA approval of its prostate cancer treatment Provenge. The Atlanta Business Chronicle reports that the Seattle biotech is considering spending $80 million on a new manufacturing plant near the Atlanta airport, a facility that could create 300 jobs.
Dendreon didn't comment on the report. But the company is in the midst of a major expansion. Last month, the PSBJ's Jeanne Lang Jones reported that Dendreon was looking to double the size of its downtown headquarters as well as secure about 250,000 square feet of lab space in the city.
It also recently announced a $50 million expansion of its plant in New Jersey.
As of last March, Dendreon employed 198 workers. But the company -- which raised $221 million last month -- has been on a hiring spree. Its Web site lists more than 75 jobs openings in Seattle and New Jersey.
READ MORE and COMMENT
No comments:
Post a Comment